56978-48-4 Usage
Uses
Used in Pharmaceutical Industry:
4-BROMO-2,3-DICHLOROANILINE is used as a chemical intermediate for the synthesis of various pharmaceuticals. Its unique structure and reactivity make it a valuable component in the development of new drugs and medicinal compounds.
Used in Dye Industry:
In the dye industry, 4-BROMO-2,3-DICHLOROANILINE is used as a precursor in the production of dyes. Its chemical properties allow for the creation of a wide range of colors and hues, contributing to the diversity of dyes available for various applications.
Used in Agrochemical Industry:
4-BROMO-2,3-DICHLOROANILINE is utilized as an intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its strong antimicrobial properties make it a useful component in the development of effective agricultural chemicals.
Used in Organic Synthesis:
4-BROMO-2,3-DICHLOROANILINE is used as a versatile building block in various organic reactions. Its reactivity and unique structure make it a valuable component in the synthesis of complex organic compounds for research and industrial applications.
Safety Precautions:
Due to its classification as a hazardous substance, 4-BROMO-2,3-DICHLOROANILINE should be handled with care. Its potential toxicity and environmental impact necessitate the adherence to proper safety precautions and disposal methods in laboratory or industrial settings.
Check Digit Verification of cas no
The CAS Registry Mumber 56978-48-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,9,7 and 8 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 56978-48:
(7*5)+(6*6)+(5*9)+(4*7)+(3*8)+(2*4)+(1*8)=184
184 % 10 = 4
So 56978-48-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H4BrCl2N/c7-3-1-2-4(10)6(9)5(3)8/h1-2H,10H2
56978-48-4Relevant academic research and scientific papers
p-Substituted Asymmetric Ureas and Medical Uses Thereof
-
Paragraph 0234; 0235, (2015/09/28)
Disclosed are compounds, compositions and methods for the prevention and/or treatment of diseases which are pathophysiologically mediated by the ghrelin receptor. The compounds have the general Formula I: or pharmaceutically acceptable salts thereof.
